Loading...

SBFM SUNSHINE BIOPHARMA INC Investments/Divestments 8-K Filing

SNSH

SBFM

SUNSHINE BIOPHARMA INC

(SBFM)

2023 8-K

Annual Meeting Results

Accounting Firm Change

Financial Statements

Securities Offering

Financial Results

Management Appointment

Annual Meeting Results

Financial Results

Management Changes

Financial Results

Exception Granted by Nasdaq

Financial Results Announcement

Appointment of Accountant

Accountant Change

Amendment to Articles of In...

Financial Results Announcement

Agreement and Reverse Stock...

Approval of Alternative Cas...

Public Offering

Buyback of Warrants

Management Appointments

Annual Meeting of Stockholders

Financial Results Announcement

Termination of Research Agr...

Amendment to Warrant Agent ...

Meeting Amendment

Notification of Non-Complia...

Earnings Reports

Private Placement

Financial Results Announcement

Amendment to Bylaws

Agreement with University o...

Compliance Regained

Research Agreement

External Links:

Sunshine Biopharma, Inc. entered into an Exclusive Patent License Agreement with the University of Arizona for technology related to inhibitors of the PLpro protease of SARS-CoV-2.

AI Assistant

SUNSHINE BIOPHARMA INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.